MO‐E‐224A‐02: Stereotactic Body Radiation Therapy: (1) Highlights of the AAPM Task Group Report 101 On SBRT

Research output: Contribution to journalArticle

Abstract

The approved charges for the AAPM Task Group 101 entitled, “Stereotactic Body Radiation Therapy”, include: Charge (1): To review the literature and identify the range of historical experiences, reported clinical findings and expected outcomes; Charge (2): To review the relevant commercial products and associated clinical findings for an assessment of system capabilities, technology limitations, and patient related expectations and outcomes; Charge (3): Determine required criteria for setting‐up and establishing an ESRT facility, including protocols, equipment, resources, and QA procedures; Charge (4): Develop consistent documentation for prescribing, reporting, and recording ESRT treatment delivery. This part of the presentation will include highlights from the current TG101 report currently under review, including strategies and requirements for patient immobilization and repositioning, respiratory management, treatment planning, and reporting.

Original languageEnglish (US)
Number of pages1
JournalMedical Physics
Volume33
Issue number6
DOIs
StatePublished - 2006
Externally publishedYes

Fingerprint

Radiotherapy
Moving and Lifting Patients
Immobilization
Documentation
Technology
Equipment and Supplies
Therapeutics

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

@article{1768af75e4824fa58349fa96e2658d0c,
title = "MO‐E‐224A‐02: Stereotactic Body Radiation Therapy: (1) Highlights of the AAPM Task Group Report 101 On SBRT",
abstract = "The approved charges for the AAPM Task Group 101 entitled, “Stereotactic Body Radiation Therapy”, include: Charge (1): To review the literature and identify the range of historical experiences, reported clinical findings and expected outcomes; Charge (2): To review the relevant commercial products and associated clinical findings for an assessment of system capabilities, technology limitations, and patient related expectations and outcomes; Charge (3): Determine required criteria for setting‐up and establishing an ESRT facility, including protocols, equipment, resources, and QA procedures; Charge (4): Develop consistent documentation for prescribing, reporting, and recording ESRT treatment delivery. This part of the presentation will include highlights from the current TG101 report currently under review, including strategies and requirements for patient immobilization and repositioning, respiratory management, treatment planning, and reporting.",
author = "Benedict, {Stanley H}",
year = "2006",
doi = "10.1118/1.2241475",
language = "English (US)",
volume = "33",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - MO‐E‐224A‐02

T2 - Stereotactic Body Radiation Therapy: (1) Highlights of the AAPM Task Group Report 101 On SBRT

AU - Benedict, Stanley H

PY - 2006

Y1 - 2006

N2 - The approved charges for the AAPM Task Group 101 entitled, “Stereotactic Body Radiation Therapy”, include: Charge (1): To review the literature and identify the range of historical experiences, reported clinical findings and expected outcomes; Charge (2): To review the relevant commercial products and associated clinical findings for an assessment of system capabilities, technology limitations, and patient related expectations and outcomes; Charge (3): Determine required criteria for setting‐up and establishing an ESRT facility, including protocols, equipment, resources, and QA procedures; Charge (4): Develop consistent documentation for prescribing, reporting, and recording ESRT treatment delivery. This part of the presentation will include highlights from the current TG101 report currently under review, including strategies and requirements for patient immobilization and repositioning, respiratory management, treatment planning, and reporting.

AB - The approved charges for the AAPM Task Group 101 entitled, “Stereotactic Body Radiation Therapy”, include: Charge (1): To review the literature and identify the range of historical experiences, reported clinical findings and expected outcomes; Charge (2): To review the relevant commercial products and associated clinical findings for an assessment of system capabilities, technology limitations, and patient related expectations and outcomes; Charge (3): Determine required criteria for setting‐up and establishing an ESRT facility, including protocols, equipment, resources, and QA procedures; Charge (4): Develop consistent documentation for prescribing, reporting, and recording ESRT treatment delivery. This part of the presentation will include highlights from the current TG101 report currently under review, including strategies and requirements for patient immobilization and repositioning, respiratory management, treatment planning, and reporting.

UR - http://www.scopus.com/inward/record.url?scp=85024816955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024816955&partnerID=8YFLogxK

U2 - 10.1118/1.2241475

DO - 10.1118/1.2241475

M3 - Article

AN - SCOPUS:85024816955

VL - 33

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -